included are historical and state of the art information on the in vitro activity , experimental in vivo activity , mode of action , pharmacokinetics , clinical studies , and uses and adverse reactions of imidazoles currently marketed ( clotrimazole , miconazole , econazole , ketoconazole , bifonazole , butoconazole , croconazole , fenticonazole , isoconazole , oxiconazole , sulconazole , and tioconazole ) and under development ( aliconazole and omoconazole ) , as well as triazoles currently marketed ( terconazole ) and under development ( fluconazole , itraconazole , vibunazole , alteconazole , and ici 195,739 ) .
C0020924
imidazoles
C0009074
clotrimazole